Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Icodec vs Insulin Glargine U100 in Adults With Type 2 Diabetes
NCT06340854Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2024
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of insulin icodec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2024; status: completed.
02
Drugs
insulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06340854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06340854.